Health Affairs, 25, no. 2 (2006): 461-468 doi: 10.1377/hlthaff.25.2.461 © 2006 by Project HOPE	New Online   House Health Reform Bill   Paying for Reform   Vetting AHIP's Report   HIV/AIDS Costs   Brief: Insurance Reform   HA Blog Top 10

This Article Abstract Full Text (HTML) Reprint (PDF) Submit a response to this article Comments: View responses Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Keyhani, S. Articles by Powe, N. Search for Related Content PubMed PubMed Citation Articles by Keyhani, S. Articles by Powe, N. Related Collections Legal/Regulatory Issues Business Of Health Pharmaceuticals Research And Technology Health Spending

Are Development Times For Pharmaceuticals Increasing Or Decreasing?

View larger version (33K): [in a new window]   EXHIBIT 3 Total Post-IND Development Period, Clinical Trial Period, And Regulatory Review Periods, By Year Of NDA Approval, 1992–2001

View larger version (32K): [in a new window]   EXHIBIT 4 Total Post-IND Development Period, Clinical Trial Period, And Regulatory Review Period, By Year Of IND Filing, 1985–1995

                      What's this?